Overview
Wholesale Trade

OLBA HEALTHCARE HOLDINGS,Inc.

OLBA Healthcare Holdings is a holding company overseeing a group of nine companies engaged primarily in the distribution of medical devices and related equipment across Japan and Southeast Asia. The group operates through three core segments: Medical Device (sales of medical equipment and related devices through subsidiaries including Kawanishi, Sansei Iki, and Nikko Medical), SPD (supply chain and procurement management services for hospitals via Hosnet Japan), and Nursing Care Products (sales and rental of home-care beds and related products via Lifecare). The group has recently expanded internationally through a joint venture in Thailand (THAI OLBA Healthcare Co., Ltd.) and into new business areas including organic waste processing equipment via newly established subsidiary Olseed.

Market Cap
US$120M
¥19.2B
EV
US$108M
¥17.3B
StockUS$11.65(¥1,860)▼-0.27%
US$1 = ¥159.70 (2026-11-12)
LTM EV/EBITDA
7.5
x
LTM EV/EBIT
11.1
x
LTM PER
19.6
x
LTM PBR
0.9
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-23.9%pt
100
Nov 13, 25 – Nov 13, 26StockTOPIX
MC → EV Bridge
US$120M¥19.2BMarket CapUS$24.3M¥3.88B+ DebtUS$34.0M¥5.43B− CashUS$2.13M¥0.34B− Inv. Sec.US$108M¥17.3BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (US$)
US$676M¥108B'22/6US$692M¥110B'23/6US$742M¥119B'24/6US$768M¥123B'25/6US$793M¥127B'26/6
EBITDA 5Y (US$)
US$15.5M¥2.48B'22/6US$16.7M¥2.66B'23/6US$17.5M¥2.79B'24/6US$16.4M¥2.62B'25/6US$15.2M¥2.42B'26/6
Net Income 5Y (US$)
US$9.61M¥1.54B'22/6US$8.85M¥1.41B'23/6US$9.39M¥1.50B'24/6US$8.95M¥1.43B'25/6US$6.96M¥1.11B'26/6
Capital Structure
84%
EquityD/E 0.19xDebt
Liquidity vs Debt 5Y (US$)▲ Net Cash
CashInv. Sec.Debt
US$21.4M¥3.41BUS$8.04M¥1.28B'22/6US$16.8M¥2.69BUS$12.0M¥1.92B'23/6US$19.3M¥3.09BUS$10.2M¥1.63B'24/6US$24.0M¥3.84BUS$18.4M¥2.95B'25/6US$18.7M¥2.98BUS$18.1M¥2.89B'26/6
Business Segments
2026/06 · US$ (¥B)
93%
Medical equipment
Revenue
US$748M(¥119B)
Segment profit
US$9.18M(¥1.47B)1.2%
4.7%
SPD
Revenue
US$38.2M(¥6.10B)
Segment profit
US$0.75M(¥0.12B)2.0%
2.3%
Care nursing goods
Revenue
US$18.2M(¥2.91B)
Segment profit
US$1.54M(¥0.25B)8.4%
Adjustments
Revenue
-US$11.7M(¥-1.87B)
Segment profit
-US$0.95M(¥-0.15B)
Shareholders
Top 10 hold 51.5%
1
Masp Co., Ltd.
13.91%
2
Tatsuya MAEJIMA
7.42%
3
OLBA HEALTHCARE HOLDINGS,Inc. Employee Stock Ownership Association
6.18%
4
The San-in Godo Bank,Ltd.
4.51%
5
The Chugoku Bank, Limited
4.49%
6
Custody Bank of Japan, Ltd. (Trust Account)
4.07%
7
Hikari Tsushin K.K. Investment Limited Partnership
3.41%
8
The Iyo Bank, Ltd.
2.67%
9
TM Teraoka Co., Ltd.
2.44%
10
Kazuo GONBIN
2.42%
Management
15 officers
Hiroshi SHIBASAKI
Representative Director, Chairman
Aug 1986 Joined Matsunaga Dental Clinic Aug 1991 Joined Herz Inc. (now DVX Inc.) Dec 1998 Sales Department Manager, DVX Inc. Jan 2003 Director, Head of Sales Division, DVX Inc. Feb 2004 Director, Head of Herz Business Division, DVX Inc. Jun 2007 Executive Officer, Head of Herz Business Division, DVX Inc. Apr 2010 Executive Officer, General Manager of Sales Headquarters, DVX Inc. Jun 2010 Director and Executive Officer, General Manager of Sales Headquarters, DVX Inc. Apr 2012 Director (Sales), DVX Inc. Apr 2015 Director (Sales and Marketing) and Executive Officer, DVX Inc. Apr 2017 Director (Arrhythmia Sales) and Executive Officer, DVX Inc. Jun 2017 Managing Director (Arrhythmia Sales) and Executive Officer, DVX Inc. Apr 2018 Managing Director (Arrhythmia Sales), DVX Inc. Jun 2018 Vice President Director (General Sales and Arrhythmia), DVX Inc. Apr 2019 Representative Director, Vice President, DVX Inc. Jun 2019 Representative Director, President, DVX Inc. Nov 2020 Director, Chairman, MSS Inc. (current) Jun 2026 Representative Director, Chairman, DVX Inc. (current) Sep 2026 Representative Director, Chairman, the Company (current)
1965-04-23
Yohei MAEJIMA
Representative Director, President
May 1991 Obtained medical license May 1991 Internal medicine residency, Okayama University Hospital Mar 1997 Obtained PhD in Medicine, Okayama University Sep 1998 Research Fellow, Harvard Medical School, USA Oct 2001 Assistant Professor, Okayama University Hospital Jan 2008 Lecturer, Okayama University Hospital Nov 2011 Professor, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University; concurrently Joint Researcher, Institute of Development, Aging and Cancer, Tohoku University Sep 2014 Director, the Company Sep 2015 Representative Director, President, the Company (current) Mar 2018 Obtained MBA, GLOBIS Graduate School of Business Administration
1967-02-05
Kyosuke ISODA
Director, General Manager of Corporate Planning Division
Mar 1997 Joined the Company Jul 2012 Manager, Corporate Planning Office, the Company Sep 2013 Director, Head of Corporate Planning Office, the Company Sep 2017 Managing Director, Head of Corporate Planning Office, the Company Jul 2021 Managing Director, General Manager of Corporate Planning Division, the Company Sep 2022 Senior Managing Director, General Manager of Corporate Planning Division, the Company Sep 2026 Director, General Manager of Corporate Planning Division, the Company (current)
1974-09-06
Satoshi SUWA
Director, General Manager of Information Systems Division
Jun 1995 Joined Herz Inc. (now DVX Inc.) Apr 2012 General Manager, Operations Department, DVX Inc. Apr 2017 General Manager, Finance and Accounting Department, DVX Inc. Apr 2021 Executive Officer, General Manager of Operations Department, DVX Inc. Jun 2024 Director (Finance, Accounting and Operations) and Executive Officer, General Manager of Operations Department, DVX Inc. Jun 2025 Director (Management Control, Human Resources, Finance, Accounting, Operations and Corporate Strategy) and Executive Officer, General Manager of Operations Department, DVX Inc. Jun 2026 Director (Management Control, Human Resources, DX and IT Promotion) and Executive Officer, General Manager of DX and IT Promotion Department, DVX Inc. (current) Sep 2026 Director, General Manager of Information Systems Division, the Company (current)
1974-01-25
Senji MURATA
Director, General Manager of Administration Division
Apr 1998 Joined the Company Jul 2006 Manager, Administration Division, the Company Sep 2013 Director, General Manager of Administration Division, the Company Sep 2017 Managing Director, General Manager of Administration Division, the Company Sep 2026 Director, General Manager of Administration Division, the Company (current)
1975-05-29
Satoshi MIYAMOTO
Director, in charge of IR and Capital Policy
Apr 1983 Joined Nomura Securities Co., Ltd. Aug 2013 Joined DVX Inc. Apr 2014 General Manager, Internal Audit Office, DVX Inc. Apr 2018 Executive Officer, DVX Inc. Jun 2018 Director (Finance, Accounting and Operations) and Executive Officer, DVX Inc. Apr 2019 Director (Finance, Accounting and Operations) and Executive Officer, General Manager of Operations Department, DVX Inc. Apr 2021 Director (Finance, Accounting and Operations), DVX Inc. Jun 2023 Director (Management Control and Human Resources; Finance, Accounting and Operations) and Executive Officer, DVX Inc. Jun 2024 Director (Management Control and Human Resources) and Executive Officer, DVX Inc. Jun 2025 Director (Overall Management), DVX Inc. Sep 2026 Director, in charge of IR and Capital Policy, the Company (current)
1959-05-24
Katsuyuki KUWAMURA
Director, General Manager of Sales Division
Apr 1997 Joined Shikoku Medical Abilities Co., Ltd. Jan 2010 Takamatsu Branch Manager, Kawanishi Co., Ltd. Jul 2014 Matsuyama Branch Manager, Kawanishi Co., Ltd. Jul 2015 Director, General Manager of Development and General Business Division, Kawanishi Co., Ltd. Jul 2017 Director, General Manager of Sales Division, Kawanishi Co., Ltd. Jul 2018 Managing Director, General Manager of Sales Division, Kawanishi Co., Ltd. Jul 2020 Assistant General Manager of Sales Division, Executive Officer, the Company Sep 2020 Director, General Manager of Sales Division, the Company Sep 2022 Managing Director, General Manager of Sales Division, the Company Sep 2026 Director, General Manager of Sales Division, the Company (current)
1974-10-09
Takeshi MIYAGAWA
Director, in charge of Compliance and Risk Management
Dec 1998 Joined Medical Soft Support Center Co., Ltd. (now MSS Inc.) Apr 2001 Joined Herz Inc. (now DVX Inc.) Dec 2002 Director, MSS Inc. Apr 2018 General Manager, Operations Department, DVX Inc. Apr 2019 General Manager, Internal Audit Office, DVX Inc. Jun 2019 Representative Director, MSS Inc. (current) Sep 2019 Representative Director, Nissei Meditech Co., Ltd. (current) Apr 2021 Executive Officer, General Manager of Internal Audit Office, DVX Inc. Jun 2022 Director (Audit and Supervisory Committee Member), DVX Inc. Sep 2026 Audit & Supervisory Board Member, DVX Inc. (current) Sep 2026 Director, in charge of Compliance and Risk Management, the Company (current)
1976-08-27
Yukiko KAWAMOTO
Director
Apr 1985 Joined Nikko Securities Co., Ltd. Jan 1995 Joined HSBC Investment Management (Japan) Ltd. (now HSBC Asset Management (Japan) Ltd.) Sep 1999 Head of Japanese Equity Investment Team, HSBC Investment Management (Japan) Ltd. Sep 2002 Director, Investment Department, HSBC Investment Management (Japan) Ltd. Nov 2003 Resigned from HSBC Investment Management (Japan) Ltd. Jan 2009 Fund Manager, Arigato Investment Trust Co., Ltd. Mar 2016 Resigned from Arigato Investment Trust Co., Ltd. Sep 2018 Outside Director, the Company (current)
1962-01-10
Toru NOJIMA
Director
Apr 1985 Joined Suzuki Tax Accountant Office Nov 1992 Joined Asahi Shinwa LLC (now Azsa LLC) Jul 2002 Associate Partner, Azsa LLC Jul 2009 Representative Partner, Azsa LLC Jul 2019 Head, Toru Nojima Certified Public Accountant Office (current) Jun 2020 Outside Director (Audit and Supervisory Committee Member), DVX Inc. Sep 2026 Outside Director, the Company (current)
1960-10-13
Sumio SUGIYAMA
Director
Mar 1977 Joined Bausch & Lomb Japan Ltd. Feb 1988 Joined Nippon Revlon B.V. Sep 1991 Joined Medtronic Japan Co., Ltd. Dec 2002 Joined Becton, Dickinson and Company Japan Apr 2006 Joined Nihon Elamedical Co., Ltd. Aug 2007 Representative Director, Sorin Japan Co., Ltd. (now LivaNova K.K.) Aug 2018 Director in charge of commercialization, iCorNet Research Institute Co., Ltd. (current) Jun 2024 Outside Director, DVX Inc. Sep 2026 Outside Director, the Company (current)
1954-07-22
Yoshihiko TAKUBO
Director
Apr 1995 Joined Mitsubishi Research Institute, Inc. May 2003 Joined Globis Corporation Apr 2006 Associate Professor, Graduate School of Management, GLOBIS University Jul 2006 Managing Director, Globis Corporation Apr 2008 Vice Dean and Professor, Graduate School of Management, GLOBIS University Dec 2009 Managing Director, Globis Educational Corporation Apr 2012 Dean and Professor, Graduate School of Management, GLOBIS University Jul 2023 Vice President and Professor, GLOBIS University Jun 2024 Outside Director, Force Startups Inc. (current) Sep 2024 Outside Director, the Company (current) Jul 2025 Special Vice President and Professor, GLOBIS University (current)
1970-04-24
Junichi MORIYA
Full-time Audit & Supervisory Board Member
Apr 1986 Joined The Chugoku Bank, Limited Feb 2008 Mikkaichi Branch Manager, The Chugoku Bank, Limited Jun 2013 Kasaoka Branch Manager, The Chugoku Bank, Limited Jun 2015 Kojima Branch Manager, The Chugoku Bank, Limited Sep 2017 Audit & Supervisory Board Member, the Company (current)
1963-04-14
Tohei NITTA
Audit & Supervisory Board Member
Aug 1981: Joined Shinwa Audit Corporation (now KPMG AZSA LLC). Mar 1984: Registered as Certified Public Accountant. May 1999: Member (now Associate Partner), KPMG AZSA LLC. May 2006: Representative Member (now Partner), KPMG AZSA LLC. Jul 2007: Head of Okayama Office, KPMG AZSA LLC. Jun 2020: Retired from KPMG AZSA LLC. Jul 2020: Established Tohei Nitta CPA Office (current). Aug 2021: Outside Director, EJ Holdings Inc. (current). Sep 2021: Audit & Supervisory Board Member, the Company (current).
1958-03-26
Akiko TANOUE
Audit & Supervisory Board Member
Dec 2001 Registered as Attorney at Law (Second Tokyo Bar Association) Dec 2006 Joined Cosmos Law Office; Partner, same office (current) Jun 2022 Outside Director (Audit and Supervisory Committee Member), DVX Inc. Sep 2026 Audit & Supervisory Board Member, the Company (current)
1967-03-05
Large Shareholding Reports
Tatsuya Maejima
2026-10-26
7.78%→0.00%
Annual report (as of 2026-06-30): 7.42%
UH6 Co., Ltd.
2026-09-08
3.55%
Takeshi MIYAGAWA
2026-09-07
0.18%
MSS Co., Ltd.
2026-09-04
16.61%
Masupu Co., Ltd.
2026-01-13
13.75%→13.75%
Annual report (as of 2026-06-30): 13.91%
Masupu Co., Ltd.
2026-01-08
13.43%→13.75%
Annual report (as of 2026-06-30): 13.91%
Tatsuya MAESHIMA
2025-07-29
—
Annual report (as of 2026-06-30): 7.42%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-10-30
Q1 Earnings Flash
FY ending Jun 2027
TDnet
2026-10-30
業績予想の修正
EDINET
2026-10-26
Large Shareholding Report
EDINET
2026-09-28
Annual Securities Report
Period: Jul 2025 – Jun 2026
EDINET
2026-09-08
Large Shareholding Report
EDINETAmended
2026-09-07
Change Report
EDINET
2026-09-04
Large Shareholding Report
TDnet
2026-08-12
Full-Year Earnings Flash
FY ending Jun 2026
TDnet
2026-04-27
Q3 Earnings Flash
FY ending Jun 2026
EDINET
2026-02-13
Semi-Annual Securities Report
Period: Jul 2025 – Jun 2026
EDINET
2026-01-13
Large Shareholding Report
EDINET
2026-01-08
Large Shareholding Report
TDnet
2025-10-31
Q1 Earnings Flash
FY ending Jun 2026
EDINET
2025-09-24
Annual Securities Report
Period: Jul 2024 – Jun 2025
TDnet
2025-08-12
Full-Year Earnings Flash
FY ending Jun 2025
EDINETAmended
2025-07-29
Change Report
TDnet
2025-04-30
Q3 Earnings Flash
FY ending Jun 2025
EDINET
2025-02-14
Semi-Annual Securities Report
Period: Jul 2024 – Jun 2025
EDINET
2024-10-31
Securities Registration Statement
TDnet
2024-10-31
Q1 Earnings Flash
FY ending Jun 2025
EDINET
2024-09-27
Annual Securities Report
Period: Jul 2023 – Jun 2024
EDINET
2024-05-15
Quarterly Securities Report
Period: Jan 2024 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-14
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-09-29
Annual Securities Report
Period: Jul 2022 – Jun 2023
EDINET
2023-05-15
Quarterly Securities Report
Period: Jan 2023 – Mar 2023
EDINET
2023-02-14
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-09-22
Annual Securities Report
EDINET
2022-08-09
Securities Registration Statement
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
Ask me!
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →